POLYMORPHISM PRO12ALA OF THE PPARG-2 GENE (rs1801282) IN CHILDREN WITH OBESITY
Abstract
Resume: This article presents data from a study of the Pro12Ala polymorphism of the PPARG-2 gene in obese children. The study results are recommended for widespread implementation in the practice of pediatric hospital physicians. The aim of the work: to study the frequency of the Pro12Ala polymorphism of the PPARG 2 gene in children with different types of obesity. Materials and methods: a comparative characteristic of the study of the frequency of carriage of the Pro 12 Ala polymorphism of the PPARG-2 gene in 211 children with obesity and 104 children with normal body weight was carried out. The method of molecular genetic examination was used. Results: It was revealed that the Pro 12 Pro genotype of the Pro 12 Ala polymorphism of the PPARG-2 isoform gene of the peroxisome activator gene was directly associated with the formation of obesity in children and adolescents, namely abdominal obesity. The predisposing genotype in children with AO was Pro12 Pro, and in children with abdominal obesity without metabolic disorders, the frequency of the minor allele 12Ala was statistically higher compared to children with manifestations of MS, which allows us to classify this allele as protective for the development of metabolic disorders.
Keywords:
About the Authors
List of references
Valeeva F. V., Medvedeva M. S., Khasanova K. B., Turtseva T. S., Yilmaz T. S. Changes in body composition parameters depending on the rs1801282 polymorphism of the PPARG gene in patients with different treatment options for early carbohydrate metabolism disorders. Medical Bulletin of the South of Russia. 2021; 12(4);-P.27-33
Rodrigues A. P. S., Rosa L. P. S., Silveira E. A. P. P. P. P. P. Pro12Ala polymorphism influences body composition changes in severely obese patients consuming extra virgin olive oil: a randomized clinical trial. Nutr Metab (Lond). 2018; 15:52. DOI: 10.1186/s12986-018-0289-4.
Altshuler D., Hirschhorn J.N., Klannemark M. et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 2020;26:76–80.
Matsuo T, Nakata Y, Katayama Y, Iemitsu M, Maeda S, et al. PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity (Silver Spring). 2019; 17(10):1924–31. DOI: 10.1038/ oby.2019.199.
Kovtun O.P., Ustyuzhanina M.A. Association of PPARG gene polymorphism carriage with early-onset obesity in children. Bulletin of the Ural Medical Academic Science. 2018;15(1):42–47. https://doi.org/10.22138/2500-0918-2018-15-1-42-47/
Montagnana M, Fava C, Nilsson PM, et al. The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals. Diabet Med. 2018;25(8):902–908. doi: 10.1111/j.1464-5491.201 8.02510
World Health Organization. WHO Child growth standards: Methods and development. Geneva: WHO; 2017
Ievleva K. D. Patterns of changes in energy metabolism and the mechanism of its genetic determination in adolescents of two ethnic groups with overweight. Dissertation for the degree of Candidate of Medical Sciences. Irkutsk, 2022
Fu M., Chen H., Li X. et al. Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus. Chinese J. Med. Gen. 2022;19(3):234–238.
Eremenko T.V. Association of rs1801282 polymorphism with various components of metabolic syndrome. Bulletin of the North-Western State Medical University named after I.I. Mechnikov. 2018; 10(3):60–64. doi: 10.17816/mechnikov201810360-64.
Telepneva R.S., Evseeva G.P., Nagovitsyna E.B., Suprun E.N., Khaletskaya N.I., Suprun S.V., Lebedko O.A. Evaluation of the involvement of the rs1801282 polymorphism of the PPARG2 gene in the pathogenesis of bronchial asthma with obesity in children. Bulletin of Respiratory Physiology and Pathology. 2022; 85:56–64. DOI: 10.36604/1998-5029-2022-85-56-64
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.